To round out our discussion on business strategies, we will briefly take a look at the concept of collusion, and how it relates to Medtronic's business operations.
Barney defines collusion as the act of any number of firms working in concert to align strategic decisions in order to decrease the competition in the respective industry.
As great a corporation Medtronic is and for as long as they have had the market share, their journey is certainly riddled with issues. In 2012, it was reported that Medtronic worked with physicians to edit and modify reports. The studies misrepresented the risks to patients of products used in spinal fusion surgery.
In late 2016, Medtronic was charged with price fixing in their China division. Medtronic was imposing minimum resale prices for products being distributed.
In late 2018, it was reported that the Brazilian regulatory bodies are filing charges against Medtronic for alleged collusion with respect to their heart devices. Specifically, Medtronic was engaging with competitors to price fix heart devices to reduce competition in the South American market.
No comments:
Post a Comment